Berlin - Delayed Quote EUR

Theravance Biopharma Inc (0TB.BE)

7.55
+0.05
+(0.67%)
As of 11:02:18 AM GMT+2. Market Open.
Loading Chart for 0TB.BE
  • Previous Close 7.50
  • Open 7.45
  • Bid 7.35 x --
  • Ask 7.85 x --
  • Day's Range 7.45 - 7.55
  • 52 Week Range 6.80 - 10.30
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 0TB.BE

View More

Performance Overview: 0TB.BE

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

0TB.BE
17.49%
S&P 500 (^GSPC)
0.19%

1-Year Return

0TB.BE
16.57%
S&P 500 (^GSPC)
11.01%

3-Year Return

0TB.BE
14.20%
S&P 500 (^GSPC)
46.44%

5-Year Return

0TB.BE
70.28%
S&P 500 (^GSPC)
105.77%

Compare To: 0TB.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0TB.BE

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    375.97M

  • Enterprise Value

    302.03M

  • Trailing P/E

    --

  • Forward P/E

    416.67

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.32

  • Price/Book (mrq)

    2.53

  • Enterprise Value/Revenue

    5.18

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0TB.BE

View More

Company Insights: 0TB.BE

Research Reports: 0TB.BE

View More